3-(2'-pyridyldithio)benzyldiazoacetate has been researched along with Ovarian Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Fan, J; Fu, Y; Guo, E; Hu, D; Hu, X; Li, Z; Liu, C; Lu, F; Qin, T; Qin, X; Sun, C; Wang, W; Xiao, R; Xiong, Y; Yang, B; Zhang, L | 1 |
1 other study(ies) available for 3-(2'-pyridyldithio)benzyldiazoacetate and Ovarian Neoplasms
| Article | Year |
|---|---|
Codelivery of adavosertib and olaparib by tumor-targeting nanoparticles for augmented efficacy and reduced toxicity.
Topics: Animals; Cell Line, Tumor; Female; Humans; Mice; Nanoparticle Drug Delivery System; Nanoparticles; Ovarian Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Tumor Microenvironment | 2023 |